MedTrace Logo

Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children

NCT06133595 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-10

No results posted yet for this study

Summary

The overall aim of the study is to evaluate the effectiveness of Mi Bridge to motivate high risk participants to admit to treatment.

The main research question is:

Is Mi Bridge, an anonymous online program based on the principles for Motivational Interviewing, effective in making high risk individuals for committing child sexual abuse prone to seek treatment for problems related to sexual interest involving children at a health care facility?

Conditions

  • Child Sexual Abuse
  • Pedophilia

Interventions

BEHAVIORAL

Behavioral: MiBridge

A series of five conversations over three weeks to help participants understand more about themselves and their willingness to change, and to help participants connect with the care they need and want.

Sponsors & Collaborators

  • Centre for Psychiatry Research, Region Stockholm, Sweden

    collaborator UNKNOWN

  • Linkoeping University

    collaborator OTHER_GOV

  • Universitat Jaume I, Spain

    collaborator UNKNOWN

  • Protect Children Organisation, Finland

    collaborator UNKNOWN

  • National Institute of Mental Health, Czech Republic

    collaborator OTHER

  • Academy of the Police Force, Bratislava, Slovakia

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-18
Primary Completion
2024-10-08
Completion
2024-10-08

Countries

  • Czechia
  • Finland
  • Germany
  • Slovakia
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133595 on ClinicalTrials.gov